NRX Therapeutics | 1.88 -0.11 -5.53% | ||
| NRXP | |||
| 高 1.99 | 开 1.96 | 量 36.58万股 | 总市值 5565.77万 |
| 低 1.86 | 换 1.24% | 额 70.05万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
NRX Therapeutics(NRXP)
02-03 06:25
$NRX Therapeutics(NRXP)$ 8-K Current report, item 5.02 Accession Number: 0001437749-26-002682 Act: 34 Size: 178 KB 网页链接
NRX Therapeutics(NRXP)
01-17 06:15
$NRX Therapeutics(NRXP)$ 8-K Current report, items 3.01, 7.01, 8.01, and 9.01 Accession Number: 0001437749-26-001455 Act: 34 Size: 208 KB 网页链接
NRX Therapeutics(NRXP)
2025-12-30 05:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-25-038835 Act: 34 Size: 275 KB 网页链接
NRX Therapeutics(NRXP)
2025-12-23 19:05
$NRX Pharmaceuticals(NRXP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003879 Act: 33 Size: 1 KB 网页链接
NRX Therapeutics(NRXP)
2025-12-23 06:25
$NRX Pharmaceuticals(NRXP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-25-038563 Act: 33 Size: 340 KB 网页链接
NRX Therapeutics(NRXP)
2025-12-13 05:35
$NRX Pharmaceuticals(NRXP)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001437749-25-037734 Act: 33 Size: 685 KB 网页链接
NRX Therapeutics(NRXP)
2025-11-27 05:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001437749-25-036452 Act: 34 Size: 247 KB 网页链接
NRX Therapeutics(NRXP)
2025-11-22 05:35
$NRX Pharmaceuticals(NRXP)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001437749-25-036005 Act: 34 Size: 1 MB 网页链接
NRX Therapeutics(NRXP)
2025-11-15 05:45
$NRX Pharmaceuticals(NRXP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-25-035210 Act: 34 Size: 14 MB 网页链接
NRX Therapeutics(NRXP)
2025-10-24 04:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001437749-25-031637 Act: 34 Size: 211 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-26 20:05
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-25-029907 Act: 34 Size: 201 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-13 04:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 2.01, 7.01, and 9.01 Accession Number: 0001437749-25-028949 Act: 34 Size: 242 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-11 03:45
$NRX Pharmaceuticals(NRXP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-024082 Size: 5 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-11 03:45
$NRX Pharmaceuticals(NRXP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-024084 Size: 5 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-11 03:45
$NRX Pharmaceuticals(NRXP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-024083 Size: 5 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-11 03:35
$NRX Pharmaceuticals(NRXP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-024081 Size: 5 KB 网页链接
NRX Therapeutics(NRXP)
2025-09-09 04:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-25-028567 Act: 34 Size: 212 KB 网页链接
NRX Therapeutics(NRXP)
2025-08-21 18:45
$NRX Pharmaceuticals(NRXP)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-079159 Act: 34 Size: 16 KB 网页链接
NRX Therapeutics(NRXP)
2025-08-21 18:25
$NRX Pharmaceuticals(NRXP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-25-079145 Size: 5 KB 网页链接
NRX Therapeutics(NRXP)
2025-08-19 04:35
$NRX Pharmaceuticals(NRXP)$ 8-K Current report, items 1.01, 2.02, 7.01, and 9.01 Accession Number: 0001437749-25-027256 Act: 34 Size: 501 KB 网页链接